Covestor’s Zenas BioPharma ZBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$0 Sell
13
-9
-41% -$277 ﹤0.01% 2934
2026
Q2
$1K Buy
22
+16
+267% +$318 ﹤0.01% 2417
2026
Q1
$0 Buy
+6
New +$135 ﹤0.01% 2872

Other funds holding ZBIO

Covestor's ZBIO Position: Q3 2026 in Review

Covestor reduced its Zenas BioPharma (ZBIO) stake by 41% in Q3 2026, selling an estimated $277 and leaving 13 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2934.

Covestor first reported a position in ZBIO in Q1 2026 and has held it in 3 quarters since. The position peaked at $1K in Q2 2026. 153 funds tracked by Wall St. Rank hold ZBIO as of Q3 2026.

  • Covestor held 13 shares of Zenas BioPharma worth $0 as of Q3 2026.
  • Covestor sold 9 Zenas BioPharma shares in Q3 2026, an estimated $277.
  • Zenas BioPharma made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2934 holding.
  • Covestor first reported a position in Zenas BioPharma in Q1 2026 and has held it in 3 quarters since.
  • Covestor's Zenas BioPharma position peaked at $1K in Q2 2026.
  • 153 funds tracked by Wall St. Rank held Zenas BioPharma as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.